Page 112 - RusRPTJul19

9.2.12 Transport corporate news
Russia’s second biggest lender VTB has acquired a 50% plus one share stake in railway holding RTC for an undisclosed amount, the bank said in a statement on Monday. “Bank VTB and the shareholders of RTC have reached an agreement and have signed binding documents oт acquisition of a 50% plus one share stake in RTC by VTB. The shareholders plan to continue to fulfill the development strategy of the company, aimed at supporting the leading positions in the segment of transportation by profile rolling stock,” VTB said. According to the statement, RTC’s priority task is to upgrade the existing grain logistic infrastructure, while other segments of business, such as timber, bulk cargo and fertilizer transportation are also to be developed.
The Federal Antimonopoly Service (FAS) refused to approve the petition of the State Transport Leasing Company ( GTLK ) to purchase the Brunswick Rail railway operator Ilya Belyaev, the agency said on June 25. According to the service,” the strengthening of the dominant position of STLCin the financial / operating car rental market, by taking over private companies, this can adversely affect the state of competition. ” GTLK is the largest leasing company in Russia: as of January 1, 2019, its portfolio amounted to RUB925.8bn, having increased by a factor of 1.7 over the year, according to the data of the rating agency Expert RA.
9.2.13 Other sector corporate news
Russian multi-industry investment conglomerate AFK Sistema has bought yet another pharmaceutical asset, announcing at the Saint Petersburg International Economic Forum (SPIEF) that it will buy stakes in Sintez and Biokom controlled by Marathon Group of Alexander Vinokurov. In April Sistema said it plans to IPO its pharmaceutical asset OBL Pharm (Obolenskoye) that was merged with Binnophafm, to reinforce its portfolio in the segment. Vedomosti daily reported last week citing unnamed sources that Sintex and Biokom deals could amount to RUB16bn, not accounting for debt. The assets of Marathon Group could jump to RUB30bn, should its produce be included in the state medicine purchasing programme. Sintez is one of the top 10 Russian medicine producers with a share of about 3% of the market, and making RUB8.6bn of revenues in 2018. Marathon controls 51% in Sintez (42% held by state technology agency Rostec) and 75% in Biokom.
Sberbank accepted the offer of Rinsoco Trading Co to repurchase 10% of Uralkali shares, the press service of the bank told Prime agency. This stake will be sold at a price of RUB89.3per share. The offer to the bank was received in mid-March. Sberbank acquired 10.18% of the common shares of Uralkali from the Rinsoco Trading in December 2018. The amount of the transaction was not disclosed. The sale price of this stake will be higher than the purchase price, the RBC source said. According to the paper the deal was a form of a loan by Sberbank to the company. Rinsoco Trading currently owns 10.18% of Uralkali's ordinary shares. Another 20% of the company's shares are owned by Dmitry Mazepin, the company’s former boss. About 56.7% of the shares are treasury shares, and 3.2% of the shares are traded on the Moscow Exchange.
Altus Capital investment fund has acquired a 29.7% stake in Russian Pharmacy chain 36.6, the companies announced on June 13. The chain is one of the largest in Russia, with RUB12.5bn of revenues in 1Q19 being the
112 RUSSIA Country Report July 2019 www.intellinews.com